Beijing News Shell Finance reported that Chen Guang Biological announced that the company will achieve a total revenue of 6.564 billion yuan in 2025, a decrease of 6.15% year-on-year; net profit attributable to shareholders of the listed company is 364 million yuan, an increase of 286.65% year-on-year.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Morning Light Biotech: Net profit attributable to parent in 2025 is expected to increase by 286.65% year-on-year
Beijing News Shell Finance reported that Chen Guang Biological announced that the company will achieve a total revenue of 6.564 billion yuan in 2025, a decrease of 6.15% year-on-year; net profit attributable to shareholders of the listed company is 364 million yuan, an increase of 286.65% year-on-year.